India’s Ranbaxy recalls generic Lipitor in U. S. , shares fall
MUMBAI (Reuters) – Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said it has recalled its cholesterol-lowering drug atorvastatin in the United States, a generic version of Lipitor that largely drove the company’s sales in the first of half the year. The recall will temporarily disrupt supplies of atorvastatin in the U. S. market while it conducts an investigation, Ranbaxy, controlled by Japan’s Daiichi Sankyo Co, said in a statement. Shares of the company fell more than 2 percent following the announcement. . . .
View full post on Health News Headlines – Yahoo! News
Leave a Reply